Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
26 |
|
Actual shortage: | 9 (35%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 17 (65%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
1 (4%) |
|
Overdue reports |
5 (56%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NAT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67512 |
NAT-DONEPEZIL | 5MG | TABLET | Resolved | 2018-07-13 | 2020-10-26 | 55625 |
NAT-DONEPEZIL | 5MG | TABLET | Resolved | 2024-02-02 | 2024-02-21 | 218262 |
NAT-DONEPEZIL | 5MG | TABLET | Actual shortage | 2024-04-29 | 2024-04-30 | 226585 |
NAT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2024-04-29 | 2024-04-30 | 226582 |
NAT-LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-04-17 | 2021-10-15 | 81921 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0